NDC 50742-611 – Oxcarbazepine
Oxcarbazepine 150 mg/1 · Tablet, Extended Release · Oral
Product NDC50742-611
Product details
- Brand name
- Oxcarbazepine
- Generic name
- Oxcarbazepine
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA215796
- Marketed since
- June 1, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Oxcarbazepine 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50742-611-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-611-01) | Jun 1, 2025 |
Other Oxcarbazepine products
- 27241-237 Oxcarbazepine 150 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 27241-238 Oxcarbazepine 300 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 27241-239 Oxcarbazepine 600 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 60505-4128 Oxcarbazepine 150 mg/1 · Tablet, Extended Release · Apotex Corp.
- 60505-4130 Oxcarbazepine 600 mg/1 · Tablet, Extended Release · Apotex Corp.
- 60505-4129 Oxcarbazepine 300 mg/1 · Tablet, Extended Release · Apotex Corp.
- 50742-612 Oxcarbazepine 300 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 50742-613 Oxcarbazepine 600 mg/1 · Tablet, Extended Release · Ingenus Pharmaceuticals, LLC
- 72888-089 Oxcarbazepine 600 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-088 Oxcarbazepine 300 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-087 Oxcarbazepine 150 mg/1 · Tablet, Film Coated · Advagen Pharma Limited
- 72888-074 Oxcarbazepine 300 mg/5mL · Suspension · Advagen Pharma Ltd